» Articles » PMID: 31467325

Abundant Neuroprotective Chaperone Lipocalin-type Prostaglandin D Synthase (L-PGDS) Disassembles the Amyloid-β Fibrils

Overview
Journal Sci Rep
Specialty Science
Date 2019 Aug 31
PMID 31467325
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Misfolding of Amyloid β (Aβ) peptides leads to the formation of extracellular amyloid plaques. Molecular chaperones can facilitate the refolding or degradation of such misfolded proteins. Here, for the first time, we report the unique ability of Lipocalin-type Prostaglandin D synthase (L-PGDS) protein to act as a disaggregase on the pre-formed fibrils of Aβ(1-40), abbreviated as Aβ40, and Aβ(25-35) peptides, in addition to inhibiting the aggregation of Aβ monomers. Furthermore, our proteomics results indicate that L-PGDS can facilitate extraction of several other proteins from the insoluble aggregates extracted from the brain of an Alzheimer's disease patient. In this study, we have established the mode of binding of L-PGDS with monomeric and fibrillar Aβ using Nuclear Magnetic Resonance (NMR) Spectroscopy, Small Angle X-ray Scattering (SAXS), and Transmission Electron Microscopy (TEM). Our results confirm a direct interaction between L-PGDS and monomeric Aβ40 and Aβ(25-35), thereby inhibiting their spontaneous aggregation. The monomeric unstructured Aβ40 binds to L-PGDS via its C-terminus, while the N-terminus remains free which is observed as a new domain in the L-PGDS-Aβ40 complex model.

Citing Articles

On the reversibility of amyloid fibril formation.

Palmadottir T, Getachew J, Ortigosa-Pascual L, Axell E, Wei J, Olsson U Biophys Rev (Melville). 2025; 6(1):011303.

PMID: 39973975 PMC: 11836874. DOI: 10.1063/5.0236947.


APOE from astrocytes restores Alzheimer's Aβ-pathology and DAM-like responses in APOE deficient microglia.

Preman P, Moechars D, Fertan E, Wolfs L, Serneels L, Shah D EMBO Mol Med. 2024; 16(12):3113-3141.

PMID: 39528861 PMC: 11628604. DOI: 10.1038/s44321-024-00162-7.


L-PGDS-PGD2-DP1 Axis Regulates Phagocytosis by CD36 MGs/MΦs That Are Exclusively Present Within Ischemic Areas After Stroke.

Nakagomi T, Narita A, Nishie H, Nakano-Doi A, Sawano T, Fukuda Y Cells. 2024; 13(20.

PMID: 39451255 PMC: 11505914. DOI: 10.3390/cells13201737.


Prostaglandins in the Inflamed Central Nervous System: Potential Therapeutic Targets.

Sheremeta C, Yarlagadda S, Smythe M, Noakes P Curr Drug Targets. 2024; 25(13):885-908.

PMID: 39177131 PMC: 11774313. DOI: 10.2174/0113894501323980240815113851.


Early predictive value of lipocalin-type prostaglandin D synthase for 28-day mortality in cardiac arrest patients: study protocol for a prospective study.

Fu H, Wang S, Xu P, Feng Z, Pan S, Ge X BMJ Open. 2024; 14(6):e083136.

PMID: 38839386 PMC: 11163600. DOI: 10.1136/bmjopen-2023-083136.


References
1.
van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark A, Berendsen H . GROMACS: fast, flexible, and free. J Comput Chem. 2005; 26(16):1701-18. DOI: 10.1002/jcc.20291. View

2.
Sana B, Johnson E, Sheah K, Poh C, Lim S . Iron-based ferritin nanocore as a contrast agent. Biointerphases. 2010; 5(3):FA48-52. DOI: 10.1116/1.3483216. View

3.
Jaru-Ampornpan P, Shen K, Lam V, Ali M, Doniach S, Jia T . ATP-independent reversal of a membrane protein aggregate by a chloroplast SRP subunit. Nat Struct Mol Biol. 2010; 17(6):696-702. PMC: 2917185. DOI: 10.1038/nsmb.1836. View

4.
Watanabe K, Urade Y, Mader M, Murphy C, HAYAISHI O . Identification of beta-trace as prostaglandin D synthase. Biochem Biophys Res Commun. 1994; 203(2):1110-6. DOI: 10.1006/bbrc.1994.2297. View

5.
Hess B . P-LINCS:  A Parallel Linear Constraint Solver for Molecular Simulation. J Chem Theory Comput. 2015; 4(1):116-22. DOI: 10.1021/ct700200b. View